Literature DB >> 3149525

Regulation of expression of carbohydrate blood group antigens.

W M Watkins1, P Greenwell, A D Yates, P H Johnson.   

Abstract

The carbohydrate antigens associated with the human ABO and Lewis blood group systems are excellent models for the study of the genetic regulation of glycoconjugate biosynthesis because their expression on erythrocytes and in saliva has been thoroughly investigated in terms of classical genetics and the chemical structures and pathways for the formation of the antigens are now well understood. The primary protein products of the blood group genes are believed to be the glycosyltransferase enzymes that complete the biosynthesis of the determinants. The important controlling factors still to be elucidated are the genetic and environmental influences leading to the tissue specific expression of these antigens. The 3 types of regulation mechanisms discussed in this review are those arising: 1) from the specificity requirements of the glycosyltransferases encoded by the blood group genes; 2) from the competition or co-operation of glycosyltransferases encoded by genes at the same or independent loci; and 3) from the existence and tissue distribution of glycosyltransferases with related, but not identical, substrate specificities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149525     DOI: 10.1016/0300-9084(88)90295-7

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

1.  Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y.

Authors:  K D Tucker; T D Wilkins
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

2.  Distribution of blood-group-related carbohydrate antigens on oral endothelial cells.

Authors:  M Bryne; S Lilleholt; P S Thrane; H S Koppang; E Dabelsteen
Journal:  Histochem J       Date:  1993-05

3.  Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in alpha3-fucosyltransferase genes.

Authors:  B J Appelmelk; S L Martin; M A Monteiro; C A Clayton; A A McColm; P Zheng; T Verboom; J J Maaskant; D H van den Eijnden; C H Hokke; M B Perry; C M Vandenbroucke-Grauls; J G Kusters
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity.

Authors:  W T Morgan; W M Watkins
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

5.  Purification of the blood group H gene associated alpha-2-L-fucosyltransferase from human plasma.

Authors:  P Kyprianou; A Betteridge; A S Donald; W M Watkins
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

6.  Enzyme-linked immunosorbent assays for the measurement of blood group A and B glycosyltransferase activities.

Authors:  L M Keshvara; E M Newton; A H Good; O Hindsgaul; M M Palcic
Journal:  Glycoconj J       Date:  1992-02       Impact factor: 2.916

7.  Carbohydrate structure of human pancreatic elastase 1.

Authors:  P Wendorf; D Linder; A Sziegoleit; R Geyer
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

Review 8.  The potential role of bacterial toxins in sudden infant death syndrome (SIDS).

Authors:  C C Blackwell; A T Saadi; M W Raza; D M Weir; A Busuttil
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

Review 9.  N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases.

Authors:  Franca Serafini-Cessi; Angela Monti; Daniela Cavallone
Journal:  Glycoconj J       Date:  2005-11       Impact factor: 3.009

Review 10.  Representing glycophenotypes: semantic unification of glycobiology resources for disease discovery.

Authors:  Jean-Philippe F Gourdine; Matthew H Brush; Nicole A Vasilevsky; Kent Shefchek; Sebastian Köhler; Nicolas Matentzoglu; Monica C Munoz-Torres; Julie A McMurry; Xingmin Aaron Zhang; Peter N Robinson; Melissa A Haendel
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.